Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03127358
What this trial is testing

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 11
Post-approval studies (Phase 4)Study completedNCT01591460
What this trial is testing

A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 165
Not applicableUnknownNCT06010524
What this trial is testing

Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

Who this might be right for
Hepatitis C
Cerrahpasa Medical Faculty Foundation 450
Testing effectiveness (Phase 2)Study completedNCT00725803
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

Who this might be right for
HCV Infection
Gilead Sciences 33
Not applicableStudy completedNCT00322179
What this trial is testing

Microarray Analysis of IFN-Induced Gene Expression in Obese and Non-Obese Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis CObesity
Palo Alto Veterans Institute for Research 22
Post-approval studies (Phase 4)Study completedNCT04575896
What this trial is testing

Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors

Who this might be right for
End Stage Renal DiseaseHepatitis C
Johns Hopkins University 10
Testing effectiveness (Phase 2)Study completedNCT01353248
What this trial is testing

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 141
Post-approval studies (Phase 4)Study completedNCT03057847
What this trial is testing

Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, ChronicOpioid-use Disorder
Elizabeth Krans, MD 32
Early research (Phase 1)Study completedNCT02666352
What this trial is testing

The Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 24
Large-scale testing (Phase 3)Study completedNCT00146016
What this trial is testing

Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients

Who this might be right for
Chronic Hepatitis C
UMC Utrecht 390
Testing effectiveness (Phase 2)Study completedNCT01434498
What this trial is testing

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Genotype 1a or 1b HCV Infection
Gilead Sciences 163
Not applicableStudy completedNCT01344889
What this trial is testing

An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUARD-C)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 4,459
Early research (Phase 1)Study completedNCT01646489
What this trial is testing

Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

Who this might be right for
Hepatitis CChronic Hepatitis C
Santaris Pharma A/S 5
Testing effectiveness (Phase 2)Study completedNCT02993250
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 33
Testing effectiveness (Phase 2)Study completedNCT05904470
What this trial is testing

A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

Who this might be right for
Chronic Hepatitis C VirusHepatitis C, ChronicHepatitis C+2 more
Atea Pharmaceuticals, Inc. 275
Testing effectiveness (Phase 2)UnknownNCT00563173
What this trial is testing

Phase I/IIa Dose Ranging CHRONVAC-C® Study in Chronic HCV Patients

Who this might be right for
Chronic Hepatitis C Virus Infection
Tripep AB 12
Post-approval studies (Phase 4)Study completedNCT00277862
What this trial is testing

Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

Who this might be right for
Hepatitis C
Ain Shams University 280
Not applicableLooking for participantsNCT01644903
What this trial is testing

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Who this might be right for
Liver TransplantHepatitis CChronic Kidney Disease+1 more
Northwestern University 1,000
Testing effectiveness (Phase 2)Study completedNCT01260350
What this trial is testing

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 292
Testing effectiveness (Phase 2)Study completedNCT01908335
What this trial is testing

A Phase Ⅱ Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Beijing Kawin Technology Share-Holding Co., Ltd. 212
Next Page